Back to results
US 5,179,008 AGranted
Hybridoma and monoclonal antibody to FHAP
AssigneeWisconsin Alumni Research Foundation
InventorsLawrence Kahan, Frank C. Larson
Life of this patent
Estimating the term…
Abstract
Antibodies, hybridomas, and immunoassays relating to a fast homoargenine-sensitive alkaline phosphatase cancer complex in serum ("FHAP") are disclosed. FHAP is a disease (e.g. cancer) marker. One aspect of the disclosure is the measuring of the physical association of two different components of FHAP as part of the assay.
Claims6
A monoclonal antibody to FHAP.
A hybridoma capable of producing a monoclonal antibody to FHAP.
Dependencies are inferred from the claim text.